BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 27221964)

  • 1. NF-κB deregulation in Hodgkin lymphoma.
    Weniger MA; Küppers R
    Semin Cancer Biol; 2016 Aug; 39():32-9. PubMed ID: 27221964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology of Hodgkin lymphoma.
    Küppers R
    Hematology Am Soc Hematol Educ Program; 2009; ():491-6. PubMed ID: 20008234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin lymphoma: Pathology and biology.
    Mathas S; Hartmann S; Küppers R
    Semin Hematol; 2016 Jul; 53(3):139-47. PubMed ID: 27496304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch and NF-κB signaling pathways in the biology of classical Hodgkin lymphoma.
    Schwarzer R; Jundt F
    Curr Mol Med; 2011 Apr; 11(3):236-45. PubMed ID: 21375490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.
    Yurchenko M; Sidorenko SP
    Exp Oncol; 2010 Dec; 32(4):214-23. PubMed ID: 21270747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
    Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
    Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
    Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.
    Lake A; Shield LA; Cordano P; Chui DT; Osborne J; Crae S; Wilson KS; Tosi S; Knight SJ; Gesk S; Siebert R; Hay RT; Jarrett RF
    Int J Cancer; 2009 Sep; 125(6):1334-42. PubMed ID: 19507254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomagenesis in Hodgkin lymphoma.
    Matsuki E; Younes A
    Semin Cancer Biol; 2015 Oct; 34():14-21. PubMed ID: 25725205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma.
    Schmitz R; Stanelle J; Hansmann ML; Küppers R
    Annu Rev Pathol; 2009; 4():151-74. PubMed ID: 19400691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
    Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
    Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare occurrence of biallelic CYLD gene mutations in classical Hodgkin lymphoma.
    Schmidt A; Schmitz R; Giefing M; Martin-Subero JI; Gesk S; Vater I; Massow A; Maggio E; Schneider M; Hansmann ML; Siebert R; Küppers R
    Genes Chromosomes Cancer; 2010 Sep; 49(9):803-9. PubMed ID: 20607853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of t(14;18) in Hodgkin's lymphoma associated with follicular lymphoma.
    Yoshida M; Ichikawa A; Miyoshi H; Takeuchi M; Kimura Y; Nino D; Ohshima K
    Pathol Int; 2012 Aug; 62(8):518-24. PubMed ID: 22827759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
    Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of NF-kappaB expression in Hodgkin's disease: inhibition of constitutively expressed NF-kappaB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Huang Q; Qin JZ; Martinez RL; Schnitzer B; Ni H; Nickoloff BJ; Alkan S
    Mod Pathol; 2001 Apr; 14(4):297-310. PubMed ID: 11301346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells.
    Schwarzer R; Dörken B; Jundt F
    Leukemia; 2012 Apr; 26(4):806-13. PubMed ID: 21946908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma.
    Otto C; Giefing M; Massow A; Vater I; Gesk S; Schlesner M; Richter J; Klapper W; Hansmann ML; Siebert R; Küppers R
    Br J Haematol; 2012 Jun; 157(6):702-8. PubMed ID: 22469134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin lymphoma.
    Küppers R; Engert A; Hansmann ML
    J Clin Invest; 2012 Oct; 122(10):3439-47. PubMed ID: 23023715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.